Innovation Pharmaceuticals Inc (IPIX): A fast track phase 2/3 for kevetrin is a...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Friday, 05/22/2015 11:01:47 AM

Friday, May 22, 2015 11:01:47 AM

A fast track phase 2/3 for kevetrin is a potential game changer. Brilacidin de-risked Ctix significantly but kevetrin is the moon shot opportunity.

Keep Last Read

Replies (2) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM

Only $200 per official company press release!